The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function-Reference-Cited by-同舟云学术

The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function

Published:2006-01-01 Issue:10 Volume:44 Page:
ISSN:1434-6621
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:
Short-container-title:

Author:

Mourad Michel,Wallemacq Pierre,De Meyer Martine,Brandt Dimitri,Van Kerkhove Valérie,Malaise Jacques,Chaïb Eddour Djamila,Lison Dominique,Haufroid Vincent

Abstract

AbstractClin Chem Lab Med 2006;44:1192–8.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry, medical,Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/CCLM.2006.229/pdf

Reference21 articles.

1. Functional polymorphisms of the human multidrug - resistance gene : multiple sequence variations and correlation of one allele with - glycoprotein expression and activity in vivo;Hoffmeyer;Proc Natl Acad Sci USA,2000

2. - glycoprotein transports cyclosporin A and FK;Saeki;J Biol Chem,1993

3. polymorphism in the MDR gene affects the enterocyte expression level of rather than Pgp in recipients of living - donor liver transplantation;Goto;Pharmacogenetics,2002

4. A more accurate method to estimate glomerular filtration rate from serum creatinine : a new prediction equation Modification of Diet in Renal Disease Study Group;Levey;Ann Intern Med,1999

5. The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation;MacPhee;Am J Transplant,2004

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic Effect of Cytochrome P450 Family 3 Subfamily A Member 5 (CYP3A5) Genetic Variants in Tacrolimus Dose Determination in Indian Renal Transplant Patients;ACS Pharmacology & Translational Science;2024-08-13

2. Pharmacogenetics of Calcineurin inhibitors in kidney transplant recipients: the African gap. A narrative review;Pharmacogenomics;2024-05-02

3. CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation;Frontiers in Pharmacology;2024-01-08

4. Tacrolimus—why pharmacokinetics matter in the clinic;Frontiers in Transplantation;2023-08-21

5. Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients;Frontiers in Pharmacology;2021-11-30